Latest News

Key Insights Given the large stake in the stock by institutions, DSV's stock price might be vulnerable to their trading...

SunOpta Inc. recently reported improved third quarter results, turning a profit, and raised its revenue guidance for 2025 to US$812 million–US$816 million, while also providing a 2026 revenue outlook of US$865 million–US$880 million. This upward revision in guidance, combined with year-over-year sales growth and positive earnings, highlights strengthened operations and management’s confidence in future performance despite a third quarter impairment charge. We’ll assess how SunOpta’s...

Cidara Therapeutics recently announced progress in its Phase 3 ANCHOR study for CD388, securing a US$45 million milestone payment from Janssen, a BARDA award valued up to US$339.2 million to support manufacturing, and receiving FDA Breakthrough Therapy designation. These updates highlight the growing validation and financial support behind CD388, a promising immunotherapeutic candidate for influenza prevention and serious diseases. We'll explore how the combination of clinical and funding...

Coca-Cola Europacific Partners PLC ( AMS:CCEP ) has announced that it will be increasing its periodic dividend on the...

The Clariane SE ( EPA:CLARI ) share price has fared very poorly over the last month, falling by a substantial 26...

Food & Life Companies recently held its 2025 earnings call on November 7, 2025, providing investors with updates on its financial and operational performance. This regular event serves as a key opportunity for stakeholders to assess the company's progress and reassess expectations going forward. With the earnings call drawing attention, we'll explore how updated financial insights may influence Food & Life Companies’ investment narrative. We've found 16 US stocks that are forecast to pay a...

PUMA SE ( ETR:PUM ) shares have had a horrible month, losing 29% after a relatively good period beforehand. For any...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

EDP, S.A. ( ELI:EDP ) shareholders are probably feeling a little disappointed, since its shares fell 9.7% to €3.89 in...

Insiders who bought UK£45.5k worth of Robert Walters plc's ( LON:RWA ) stock at an average buy price of UK£2.46 over...

Dalekovod d.d.'s ( ZGSE:DLKV ) stock was strong after they recently reported robust earnings. We did some analysis and...

Key Insights Komax Holding's estimated fair value is CHF86.57 based on 2 Stage Free Cash Flow to Equity Current share...

With a price-to-earnings (or "P/E") ratio of 24.2x Infrastrutture Wireless Italiane S.p.A. ( BIT:INW ) may be sending...

The quarterly results for Leifheit Aktiengesellschaft ( ETR:LEI ) were released last week, making it a good time to...

Prelude Therapeutics (PRLD) is shaking up its strategy with news of a major exclusive option agreement with Incyte and a renewed focus on its KAT6A breast cancer program. The company is also pausing the SMARCA2 clinical effort. See our latest analysis for Prelude Therapeutics. Prelude’s string of announcements, including the Incyte partnership, SMARCA2 pause, and executive change, has made for a volatile stretch, with the stock tumbling 25% over the last week alone. Share price momentum...

Delivery Hero SE ( ETR:DHER ) shareholders that were waiting for something to happen have been dealt a blow with a 27...

Key Insights Given the large stake in the stock by institutions, MLP's stock price might be vulnerable to their trading...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

It's been a sad week for Zaptec ASA ( OB:ZAP ), who've watched their investment drop 12% to kr26.05 in the week since...

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

Key Insights Italtile's Annual General Meeting to take place on 13th of November CEO Lance Foxcroft's total...